William Blair Assigns Outperform On Infinity Pharmaceuticals Shares, $18 PT

In a research report issued today, William Blair analyst Y Katherine Xu assigned an Outperform rating on Infinity Pharmaceuticals (NASDAQ:INFI) with a price target of $18.00.

According to TipRanks.com, which measures analysts’ and bloggers’ success rate based on how their calls perform, analyst Y Katherine Xu has a total average return of -4.5% and a 40.0% success rate. Xu is ranked #2843 out of 3352 analysts.

INFY Chart


Stay Ahead of Everyone Else

Get The Latest Stock News Alerts